153 related articles for article (PubMed ID: 36121088)
1. Long Non-coding RNA DLGAP1-AS1 and DLGAP1-AS2: Two Novel Oncogenes in Multiple Cancers.
Zhao F; Tan F; Tang L; Du Z; Chen X; Yang Y; Zhou G; Yuan C
Curr Med Chem; 2023; 30(25):2822-2834. PubMed ID: 36121088
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA DLGAP1-AS1 promotes cell proliferation in hepatocellular carcinoma via sequestering miR-486-5p.
Peng X; Wei F; Hu X
J Cell Biochem; 2020 Feb; 121(2):1953-1962. PubMed ID: 31633236
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA DLGAP1-AS1 facilitates tumorigenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via the feedback loop of miR-26a/b-5p/IL-6/JAK2/STAT3 and Wnt/β-catenin pathway.
Lin Y; Jian Z; Jin H; Wei X; Zou X; Guan R; Huang J
Cell Death Dis; 2020 Jan; 11(1):34. PubMed ID: 31949128
[TBL] [Abstract][Full Text] [Related]
4. LncRNA DLGAP1-AS2 modulates glioma development by up-regulating YAP1 expression.
Miao W; Li N; Gu B; Yi G; Su Z; Cheng H
J Biochem; 2020 Apr; 167(4):411-418. PubMed ID: 31899508
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA DLGAP1 antisense RNA 1 accelerates glioma progression via the microRNA-628-5p/DEAD-box helicase 59 pathway.
Hu KQ; Ao XS
Clinics (Sao Paulo); 2022; 77():100002. PubMed ID: 35113786
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA DLGAP1-AS1 promotes the progression of glioma by regulating the miR-1297/EZH2 axis.
Liu L; Li X; Shi Y; Chen H
Aging (Albany NY); 2021 Apr; 13(8):12129-12142. PubMed ID: 33901010
[TBL] [Abstract][Full Text] [Related]
7. lncRNA DLGAP1-AS2 Knockdown Inhibits Hepatocellular Carcinoma Cell Migration and Invasion by Regulating miR-154-5p Methylation.
Chen K; Zhang Z; Yu A; Li J; Liu J; Zhang X
Biomed Res Int; 2020; 2020():6575724. PubMed ID: 33195697
[TBL] [Abstract][Full Text] [Related]
8. The long noncoding RNA DLGAP1-AS2 facilitates cholangiocarcinoma progression via miR-505 and GALNT10.
Liu Z; Pan L; Yan X; Duan X
FEBS Open Bio; 2021 Feb; 11(2):413-422. PubMed ID: 33301605
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA DLGAP1-AS2 promotes tumorigenesis and metastasis by regulating the Trim21/ELOA/LHPP axis in colorectal cancer.
Wang X; Cheng H; Zhao J; Li J; Chen Y; Cui K; Tian L; Zhang J; Li C; Sun S; Feng Y; Yao S; Bian Z; Huang S; Fei B; Huang Z
Mol Cancer; 2022 Nov; 21(1):210. PubMed ID: 36376892
[TBL] [Abstract][Full Text] [Related]
10. The knockdown of lncRNA DLGAP1-AS2 suppresses osteosarcoma progression by inhibiting aerobic glycolysis via the miR-451a/HK2 axis.
Zheng C; Li R; Zheng S; Fang H; Xu M; Zhong L
Cancer Sci; 2023 Dec; 114(12):4747-4762. PubMed ID: 37817462
[TBL] [Abstract][Full Text] [Related]
11. LncRNA DLGAP1-AS2 regulates miR-503/cyclin D1 to promote cell proliferation in non-small cell lung cancer.
Wang L; Tang L; Ge T; Zhu F; Liu D; Guo H; Qian P; Xu N
BMC Pulm Med; 2021 Aug; 21(1):277. PubMed ID: 34454450
[TBL] [Abstract][Full Text] [Related]
12. In Silico Analysis Identifies Upregulated lncRNA DLGAP1-AS1 Which Is Correlated to Poor Prognosis and Promotes Cell Proliferation in Glioblastoma.
Huang Y; Liu L; Fang M; Yan W
Comput Math Methods Med; 2022; 2022():5038124. PubMed ID: 35341001
[TBL] [Abstract][Full Text] [Related]
13. LncRNA DLGAP1-AS1 accelerates glioblastoma cell proliferation through targeting miR-515-5p/ROCK1/NFE2L1 axis and activating Wnt signaling pathway.
Wang Z; Han Y; Li Q; Wang B; Ma J
Brain Behav; 2021 Oct; 11(10):e2321. PubMed ID: 34536977
[TBL] [Abstract][Full Text] [Related]
14. DLGAP1-AS2 promotes human colorectal cancer progression through trans-activation of Myc.
Ren C; Han H; Pan J; Chang Q; Wang W; Guo X; Bian J
Mamm Genome; 2022 Dec; 33(4):672-683. PubMed ID: 36222892
[TBL] [Abstract][Full Text] [Related]
15. LncRNA DLGAP1-AS2 overexpression associates with gastric tumorigenesis: a promising diagnostic and therapeutic target.
Soltani R; Amini M; Mazaheri Moghaddam M; Jebelli A; Ahmadiyan S; Bidar N; Baradaran B; MotieGhader H; Asadi M; Mokhtarzadeh A
Mol Biol Rep; 2022 Jul; 49(7):6817-6826. PubMed ID: 34981339
[TBL] [Abstract][Full Text] [Related]
16. METTL3-induced DLGAP1-AS2 promotes non-small cell lung cancer tumorigenesis through m
Zhang Q; Zhang Y; Chen H; Sun LN; Zhang B; Yue DS; Wang CL; Zhang ZF
Cell Cycle; 2022 Dec; 21(24):2602-2614. PubMed ID: 35972892
[TBL] [Abstract][Full Text] [Related]
17. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA LPP-AS2 promotes glioma tumorigenesis via miR-7-5p/EGFR/PI3K/AKT/c-MYC feedback loop.
Zhang X; Niu W; Mu M; Hu S; Niu C
J Exp Clin Cancer Res; 2020 Sep; 39(1):196. PubMed ID: 32962742
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
